Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 9.53401908 |
2 | polyketide metabolic process (GO:0030638) | 8.08864482 |
3 | doxorubicin metabolic process (GO:0044598) | 8.08864482 |
4 | daunorubicin metabolic process (GO:0044597) | 8.08864482 |
5 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 7.73314839 |
6 | T-helper cell differentiation (GO:0042093) | 7.73314839 |
7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 7.48034758 |
8 | lysine catabolic process (GO:0006554) | 7.12810579 |
9 | lysine metabolic process (GO:0006553) | 7.12810579 |
10 | urate metabolic process (GO:0046415) | 6.91572695 |
11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.91417317 |
12 | negative regulation of thymocyte apoptotic process (GO:0070244) | 6.83894479 |
13 | alpha-beta T cell activation involved in immune response (GO:0002287) | 6.76355117 |
14 | T cell differentiation involved in immune response (GO:0002292) | 6.76355117 |
15 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 6.76355117 |
16 | sleep (GO:0030431) | 6.54163224 |
17 | drug transmembrane transport (GO:0006855) | 6.41521249 |
18 | mucosal-associated lymphoid tissue development (GO:0048537) | 6.16986255 |
19 | Peyers patch development (GO:0048541) | 6.16986255 |
20 | cellular modified amino acid catabolic process (GO:0042219) | 6.08264819 |
21 | negative regulation of glycogen biosynthetic process (GO:0045719) | 5.98266399 |
22 | positive regulation of antigen processing and presentation (GO:0002579) | 5.80009086 |
23 | drug transport (GO:0015893) | 5.76293299 |
24 | lymph node development (GO:0048535) | 5.65443248 |
25 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.62963432 |
26 | cytidine deamination (GO:0009972) | 5.60198576 |
27 | cytidine metabolic process (GO:0046087) | 5.60198576 |
28 | cytidine catabolic process (GO:0006216) | 5.60198576 |
29 | regulation of response to osmotic stress (GO:0047484) | 5.57947689 |
30 | negative regulation of T cell apoptotic process (GO:0070233) | 5.48745192 |
31 | poly(A)+ mRNA export from nucleus (GO:0016973) | 5.42276387 |
32 | transepithelial transport (GO:0070633) | 5.41970828 |
33 | cysteine metabolic process (GO:0006534) | 5.39197474 |
34 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.37267363 |
35 | modified amino acid transport (GO:0072337) | 5.33517230 |
36 | negative regulation of skeletal muscle tissue development (GO:0048642) | 5.31812335 |
37 | phosphate ion transport (GO:0006817) | 5.30620353 |
38 | response to gravity (GO:0009629) | 5.25664530 |
39 | excretion (GO:0007588) | 5.22726077 |
40 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 5.18977710 |
41 | * organic cation transport (GO:0015695) | 5.08754074 |
42 | response to muramyl dipeptide (GO:0032495) | 5.07979064 |
43 | valine metabolic process (GO:0006573) | 5.04929620 |
44 | biotin metabolic process (GO:0006768) | 4.94388047 |
45 | regulation of germinal center formation (GO:0002634) | 4.92845043 |
46 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 4.86189264 |
47 | hormone catabolic process (GO:0042447) | 4.86136825 |
48 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 4.85520603 |
49 | germ cell migration (GO:0008354) | 4.79703172 |
50 | quaternary ammonium group transport (GO:0015697) | 4.79620275 |
51 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 4.78633606 |
52 | phosphate ion transmembrane transport (GO:0035435) | 4.75943262 |
53 | negative regulation of epidermis development (GO:0045683) | 4.75931540 |
54 | negative regulation of meiotic cell cycle (GO:0051447) | 4.71849770 |
55 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.69512691 |
56 | somite rostral/caudal axis specification (GO:0032525) | 4.64934385 |
57 | negative regulation of glycogen metabolic process (GO:0070874) | 4.62253422 |
58 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.60502756 |
59 | negative regulation of cell killing (GO:0031342) | 4.60502756 |
60 | positive regulation of circadian rhythm (GO:0042753) | 4.59669373 |
61 | indole-containing compound catabolic process (GO:0042436) | 4.59193797 |
62 | indolalkylamine catabolic process (GO:0046218) | 4.59193797 |
63 | tryptophan catabolic process (GO:0006569) | 4.59193797 |
64 | regulation of antigen processing and presentation (GO:0002577) | 4.58657069 |
65 | L-ascorbic acid metabolic process (GO:0019852) | 4.57631117 |
66 | cellular response to sterol (GO:0036315) | 4.57378364 |
67 | maintenance of protein location in nucleus (GO:0051457) | 4.55119086 |
68 | vitamin D metabolic process (GO:0042359) | 4.50917792 |
69 | regulation of gamma-delta T cell activation (GO:0046643) | 4.49777517 |
70 | branched-chain amino acid metabolic process (GO:0009081) | 4.48000974 |
71 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 4.46305492 |
72 | regulation of memory T cell differentiation (GO:0043380) | 4.45620205 |
73 | aspartate family amino acid catabolic process (GO:0009068) | 4.45258280 |
74 | coenzyme catabolic process (GO:0009109) | 4.42426940 |
75 | response to mercury ion (GO:0046689) | 4.41463623 |
76 | 2-oxoglutarate metabolic process (GO:0006103) | 4.36061910 |
77 | sulfur amino acid catabolic process (GO:0000098) | 4.31606720 |
78 | kynurenine metabolic process (GO:0070189) | 4.28409515 |
79 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 4.26202397 |
80 | cytokine biosynthetic process (GO:0042089) | 4.24284697 |
81 | positive regulation of digestive system process (GO:0060456) | 4.20349447 |
82 | renal absorption (GO:0070293) | 4.18402396 |
83 | tryptophan metabolic process (GO:0006568) | 4.17675792 |
84 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 4.17325552 |
85 | regulation of thymocyte apoptotic process (GO:0070243) | 4.14890912 |
86 | glyoxylate metabolic process (GO:0046487) | 4.10251922 |
87 | mitotic cell cycle arrest (GO:0071850) | 4.06944564 |
88 | muscle organ morphogenesis (GO:0048644) | 4.06860716 |
89 | nonribosomal peptide biosynthetic process (GO:0019184) | 4.06803602 |
90 | branched-chain amino acid catabolic process (GO:0009083) | 4.06536062 |
91 | vitamin transmembrane transport (GO:0035461) | 3.99186874 |
92 | regulation of tyrosine phosphorylation of Stat1 protein (GO:0042510) | 3.97011933 |
93 | negative regulation of glucose transport (GO:0010829) | 3.93597474 |
94 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.92001514 |
95 | aromatic amino acid family catabolic process (GO:0009074) | 3.91943525 |
96 | metanephric tubule development (GO:0072170) | 3.91160974 |
97 | metanephric nephron tubule development (GO:0072234) | 3.91160974 |
98 | RNA destabilization (GO:0050779) | 3.88568462 |
99 | regulation of chronic inflammatory response (GO:0002676) | 3.86594887 |
100 | fructose metabolic process (GO:0006000) | 3.84128305 |
101 | positive regulation of T cell cytokine production (GO:0002726) | 3.83081892 |
102 | cytokine production involved in immune response (GO:0002367) | 3.82928793 |
103 | glycoside metabolic process (GO:0016137) | 3.81914374 |
104 | cofactor transport (GO:0051181) | 3.78813688 |
105 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 3.76371619 |
106 | glutathione biosynthetic process (GO:0006750) | 3.75450676 |
107 | serine family amino acid catabolic process (GO:0009071) | 3.74868300 |
108 | peptidyl-threonine dephosphorylation (GO:0035970) | 3.73901084 |
109 | alpha-beta T cell differentiation (GO:0046632) | 3.72449928 |
110 | sulfur compound transport (GO:0072348) | 3.71304815 |
111 | ER overload response (GO:0006983) | 3.71216781 |
112 | response to phenylpropanoid (GO:0080184) | 3.68329845 |
113 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 3.68308225 |
114 | inactivation of MAPK activity (GO:0000188) | 3.64214083 |
115 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.62122524 |
116 | dicarboxylic acid catabolic process (GO:0043649) | 3.61968906 |
117 | mast cell activation involved in immune response (GO:0002279) | 3.61782548 |
118 | mast cell degranulation (GO:0043303) | 3.61782548 |
119 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.61099762 |
120 | protein localization to kinetochore (GO:0034501) | 3.56865704 |
121 | tricarboxylic acid metabolic process (GO:0072350) | 3.56858123 |
122 | homocysteine metabolic process (GO:0050667) | 3.55761047 |
123 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.55397884 |
124 | short-chain fatty acid metabolic process (GO:0046459) | 3.55353836 |
125 | quinone metabolic process (GO:1901661) | 3.55081857 |
126 | fat-soluble vitamin metabolic process (GO:0006775) | 3.54456238 |
127 | ribonucleoprotein complex disassembly (GO:0032988) | 3.54349171 |
128 | amino acid transmembrane transport (GO:0003333) | 3.53132601 |
129 | metanephric nephron epithelium development (GO:0072243) | 3.52567209 |
130 | histone H4-K8 acetylation (GO:0043982) | 3.51316933 |
131 | histone H4-K5 acetylation (GO:0043981) | 3.51316933 |
132 | epoxygenase P450 pathway (GO:0019373) | 3.50905690 |
133 | serine family amino acid metabolic process (GO:0009069) | 3.50859426 |
134 | cytokine metabolic process (GO:0042107) | 3.50665414 |
135 | endoderm formation (GO:0001706) | 3.49108141 |
136 | rRNA transcription (GO:0009303) | 3.48846872 |
137 | cardiovascular system development (GO:0072358) | 3.47588602 |
138 | negative regulation of glucose import (GO:0046325) | 3.45871700 |
139 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.45415546 |
140 | nucleoside transmembrane transport (GO:1901642) | 3.45315419 |
141 | vitamin transport (GO:0051180) | 3.44391010 |
142 | interferon-gamma production (GO:0032609) | 3.42971171 |
143 | production of molecular mediator of immune response (GO:0002440) | 3.39702883 |
144 | acetyl-CoA metabolic process (GO:0006084) | 3.37206990 |
145 | regulation of transcription involved in cell fate commitment (GO:0060850) | 3.36970156 |
146 | hypotonic response (GO:0006971) | 3.34509938 |
147 | negative regulation of telomerase activity (GO:0051974) | 3.34044029 |
148 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.32195234 |
149 | drug metabolic process (GO:0017144) | 3.31522411 |
150 | alpha-beta T cell activation (GO:0046631) | 3.30181039 |
151 | regulation of T cell apoptotic process (GO:0070232) | 3.29136831 |
152 | regulation of telomere maintenance via telomerase (GO:0032210) | 3.28569950 |
153 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 3.28264742 |
154 | notochord development (GO:0030903) | 3.28130835 |
155 | regulation of hippo signaling (GO:0035330) | 3.25017449 |
156 | glutamate metabolic process (GO:0006536) | 3.24387528 |
157 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.23538367 |
158 | leukocyte aggregation (GO:0070486) | 3.23516523 |
159 | L-phenylalanine metabolic process (GO:0006558) | 3.22622116 |
160 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.22622116 |
161 | cellular amino acid catabolic process (GO:0009063) | 3.21038043 |
162 | positive regulation of heat generation (GO:0031652) | 3.20691927 |
163 | amino-acid betaine metabolic process (GO:0006577) | 3.19278962 |
164 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.18054176 |
165 | polyol transport (GO:0015791) | 3.17989472 |
166 | phenol-containing compound catabolic process (GO:0019336) | 3.16273450 |
167 | toxin transport (GO:1901998) | 3.15774032 |
168 | T cell activation involved in immune response (GO:0002286) | 3.15572496 |
169 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.15180043 |
170 | metanephric epithelium development (GO:0072207) | 3.15153157 |
171 | protein-cofactor linkage (GO:0018065) | 3.12408721 |
172 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 3.11309868 |
173 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.10673219 |
174 | regulation of regulatory T cell differentiation (GO:0045589) | 3.09652748 |
175 | negative regulation of lipid storage (GO:0010888) | 3.08694950 |
176 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.07876586 |
177 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.07876586 |
178 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.03586946 |
179 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.03280103 |
180 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.03120216 |
181 | protein K11-linked deubiquitination (GO:0035871) | 3.03064190 |
182 | regulation of RNA export from nucleus (GO:0046831) | 3.02687388 |
183 | negative regulation of interleukin-1 production (GO:0032692) | 3.01338639 |
184 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 3.00371853 |
185 | negative regulation of leukocyte apoptotic process (GO:2000107) | 2.99636290 |
186 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.97430790 |
187 | response to sterol (GO:0036314) | 2.96445499 |
188 | negative regulation of innate immune response (GO:0045824) | 2.95648119 |
189 | positive regulation of osteoclast differentiation (GO:0045672) | 2.95570569 |
190 | tolerance induction (GO:0002507) | 2.89809527 |
191 | striated muscle atrophy (GO:0014891) | 2.87833559 |
192 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.83743672 |
193 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.83743672 |
194 | meiotic chromosome segregation (GO:0045132) | 2.79956046 |
195 | dendritic cell chemotaxis (GO:0002407) | 2.79802299 |
196 | regulation of integrin activation (GO:0033623) | 2.78845754 |
197 | aminoglycoside antibiotic metabolic process (GO:0030647) | 11.2320309 |
198 | antigen processing and presentation via MHC class Ib (GO:0002475) | 10.5045172 |
Rank | Gene Set | Z-score |
---|---|---|
1 | GATA1_22025678_ChIP-Seq_K562_Human | 9.27650460 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.73760031 |
3 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 6.65271834 |
4 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 6.03672890 |
5 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 6.03672890 |
6 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 6.03672890 |
7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.95722627 |
8 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.46237837 |
9 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 3.43607622 |
10 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 3.26980410 |
11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.06754175 |
12 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.87169262 |
13 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.83442779 |
14 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.78279910 |
15 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.76315924 |
16 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.70317323 |
17 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.67612978 |
18 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.63393920 |
19 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 2.60234441 |
20 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.59403392 |
21 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.54962021 |
22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.51680528 |
23 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.40275332 |
24 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.38078915 |
25 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.26749636 |
26 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 2.25728694 |
27 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.16177990 |
28 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.13409272 |
29 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.08274389 |
30 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 2.05014314 |
31 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.94218363 |
32 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.92130669 |
33 | MYB_26560356_Chip-Seq_TH2_Human | 1.89295032 |
34 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.86177466 |
35 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.84319315 |
36 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.81908622 |
37 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.78051869 |
38 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.75960524 |
39 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.73804813 |
40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.73152137 |
41 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.72478263 |
42 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.69331435 |
43 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.66507078 |
44 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.64328198 |
45 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.63288790 |
46 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.62447534 |
47 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.61862798 |
48 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.60169970 |
49 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.59816605 |
50 | UTX_26944678_Chip-Seq_JUKART_Human | 1.58002571 |
51 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.57820113 |
52 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.57637962 |
53 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.56970573 |
54 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.55674432 |
55 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50063161 |
56 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.49532203 |
57 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.48713906 |
58 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48205005 |
59 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.44433070 |
60 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.42226180 |
61 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.40483095 |
62 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.39694251 |
63 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.39065696 |
64 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.36688917 |
65 | MAF_26560356_Chip-Seq_TH1_Human | 1.35820951 |
66 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.35635912 |
67 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.35600479 |
68 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.33933061 |
69 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 1.33728879 |
70 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.33446695 |
71 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33230252 |
72 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.31436671 |
73 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.29894330 |
74 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.27736228 |
75 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.26630259 |
76 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.25505445 |
77 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.25336465 |
78 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.24234319 |
79 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.23154024 |
80 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.21730786 |
81 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.21177247 |
82 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.19815903 |
83 | MYB_26560356_Chip-Seq_TH1_Human | 1.18416492 |
84 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.18111051 |
85 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.15595411 |
86 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.15036578 |
87 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.14188216 |
88 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.12848505 |
89 | VDR_22108803_ChIP-Seq_LS180_Human | 1.12259583 |
90 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.11875562 |
91 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.11801092 |
92 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.11719183 |
93 | MAF_26560356_Chip-Seq_TH2_Human | 1.10286867 |
94 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.10111967 |
95 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.10008444 |
96 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.07969761 |
97 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.06275505 |
98 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.05805576 |
99 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.04630869 |
100 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.03035126 |
101 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.02834144 |
102 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.02353108 |
103 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.01371437 |
104 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.01266163 |
105 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01048064 |
106 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.01006969 |
107 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.00138143 |
108 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99935276 |
109 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.99912589 |
110 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.98899894 |
111 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98777279 |
112 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.98241680 |
113 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.96212121 |
114 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.96107154 |
115 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.96097500 |
116 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95295646 |
117 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.95108797 |
118 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.93179482 |
119 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92754601 |
120 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.92640635 |
121 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.92083557 |
122 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91200940 |
123 | GATA3_26560356_Chip-Seq_TH2_Human | 0.91041320 |
124 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.90902614 |
125 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.90410689 |
126 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.90229838 |
127 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.89128375 |
128 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.88906149 |
129 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.87873245 |
130 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.87583710 |
131 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.87115286 |
132 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.86709228 |
133 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.86699729 |
134 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.86223852 |
135 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.85995622 |
136 | P68_20966046_ChIP-Seq_HELA_Human | 0.84570941 |
137 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84072553 |
138 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83934553 |
139 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.83141200 |
140 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.82893157 |
141 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.82880423 |
142 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.82687043 |
143 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.82545661 |
144 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.82400682 |
145 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.82149173 |
146 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.81930741 |
147 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.81825694 |
148 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.81730280 |
149 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81615620 |
150 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.81351329 |
151 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.81065718 |
152 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.80987182 |
153 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.80234937 |
154 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.80119319 |
155 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.80006948 |
156 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.78969525 |
157 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.78448499 |
158 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.78419365 |
159 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77723821 |
160 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.77599643 |
161 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.77505938 |
162 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.77447939 |
163 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.77097004 |
164 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.77037249 |
165 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.76948375 |
166 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.76846452 |
167 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.76351097 |
168 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.76331373 |
169 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.75329875 |
170 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.74793416 |
171 | MYC_22102868_ChIP-Seq_BL_Human | 0.74316053 |
172 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.74112589 |
173 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.74102129 |
174 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.74042178 |
175 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.73057532 |
176 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.72277102 |
177 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.70870908 |
178 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.70533792 |
179 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.70391189 |
180 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.70384760 |
181 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.69593177 |
182 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.68828488 |
183 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.68571856 |
184 | BCL6_25482012_ChIP-Seq_CML-JURL-MK1_Human | 0.68529589 |
185 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.68360081 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003724_increased_susceptibility_to | 6.58261452 |
2 | MP0004043_abnormal_pH_regulation | 6.16958891 |
3 | MP0005360_urolithiasis | 6.04296197 |
4 | MP0004147_increased_porphyrin_level | 4.76803762 |
5 | MP0005671_abnormal_response_to | 4.54273871 |
6 | MP0004264_abnormal_extraembryonic_tissu | 4.03174709 |
7 | MP0005332_abnormal_amino_acid | 3.75824321 |
8 | MP0003436_decreased_susceptibility_to | 3.61094034 |
9 | MP0004019_abnormal_vitamin_homeostasis | 3.60521585 |
10 | MP0003011_delayed_dark_adaptation | 3.13024582 |
11 | MP0003763_abnormal_thymus_physiology | 3.02262499 |
12 | MP0003656_abnormal_erythrocyte_physiolo | 3.01783616 |
13 | MP0003195_calcinosis | 2.96021061 |
14 | MP0009643_abnormal_urine_homeostasis | 2.89240618 |
15 | MP0004947_skin_inflammation | 2.87976968 |
16 | MP0008961_abnormal_basal_metabolism | 2.87581465 |
17 | MP0002933_joint_inflammation | 2.85086485 |
18 | MP0002254_reproductive_system_inflammat | 2.80909032 |
19 | MP0004858_abnormal_nervous_system | 2.77928133 |
20 | MP0009785_altered_susceptibility_to | 2.60010476 |
21 | MP0001765_abnormal_ion_homeostasis | 2.55824941 |
22 | MP0000569_abnormal_digit_pigmentation | 2.55366077 |
23 | MP0001835_abnormal_antigen_presentation | 2.52559792 |
24 | MP0001756_abnormal_urination | 2.51509312 |
25 | MP0010386_abnormal_urinary_bladder | 2.50996742 |
26 | MP0006292_abnormal_olfactory_placode | 2.40452579 |
27 | MP0002139_abnormal_hepatobiliary_system | 2.40132146 |
28 | MP0003890_abnormal_embryonic-extraembry | 2.33854913 |
29 | MP0005394_taste/olfaction_phenotype | 2.26795000 |
30 | MP0005499_abnormal_olfactory_system | 2.26795000 |
31 | MP0002009_preneoplasia | 2.25658946 |
32 | MP0001501_abnormal_sleep_pattern | 2.23377338 |
33 | MP0006035_abnormal_mitochondrial_morpho | 2.23039606 |
34 | MP0005377_hearing/vestibular/ear_phenot | 2.21276730 |
35 | MP0003878_abnormal_ear_physiology | 2.21276730 |
36 | MP0005000_abnormal_immune_tolerance | 2.20976734 |
37 | MP0008875_abnormal_xenobiotic_pharmacok | 2.15563856 |
38 | MP0002136_abnormal_kidney_physiology | 2.10718961 |
39 | MP0005174_abnormal_tail_pigmentation | 2.09241837 |
40 | MP0003828_pulmonary_edema | 2.08237732 |
41 | MP0005636_abnormal_mineral_homeostasis | 2.03974825 |
42 | MP0002332_abnormal_exercise_endurance | 1.99130267 |
43 | MP0002166_altered_tumor_susceptibility | 1.97559465 |
44 | MP0001533_abnormal_skeleton_physiology | 1.96728873 |
45 | MP0002138_abnormal_hepatobiliary_system | 1.83524707 |
46 | MP0001188_hyperpigmentation | 1.83485099 |
47 | MP0003122_maternal_imprinting | 1.78347148 |
48 | MP0005257_abnormal_intraocular_pressure | 1.75319585 |
49 | MP0005075_abnormal_melanosome_morpholog | 1.74716351 |
50 | MP0002723_abnormal_immune_serum | 1.64583326 |
51 | MP0005025_abnormal_response_to | 1.62268375 |
52 | MP0002148_abnormal_hypersensitivity_rea | 1.61887220 |
53 | MP0003283_abnormal_digestive_organ | 1.61399129 |
54 | MP0002877_abnormal_melanocyte_morpholog | 1.61358265 |
55 | MP0003705_abnormal_hypodermis_morpholog | 1.60712001 |
56 | MP0001243_abnormal_dermal_layer | 1.57125804 |
57 | MP0002419_abnormal_innate_immunity | 1.56145026 |
58 | MP0010234_abnormal_vibrissa_follicle | 1.55874583 |
59 | MP0000678_abnormal_parathyroid_gland | 1.54695200 |
60 | MP0000685_abnormal_immune_system | 1.53961146 |
61 | MP0001851_eye_inflammation | 1.52324567 |
62 | MP0001984_abnormal_olfaction | 1.50600740 |
63 | MP0003943_abnormal_hepatobiliary_system | 1.49982929 |
64 | MP0001986_abnormal_taste_sensitivity | 1.49117948 |
65 | MP0003787_abnormal_imprinting | 1.48948475 |
66 | MP0004130_abnormal_muscle_cell | 1.48742479 |
67 | MP0003938_abnormal_ear_development | 1.46906615 |
68 | MP0002006_tumorigenesis | 1.45887276 |
69 | MP0005365_abnormal_bile_salt | 1.45346343 |
70 | MP0001800_abnormal_humoral_immune | 1.44034718 |
71 | MP0004957_abnormal_blastocyst_morpholog | 1.41998757 |
72 | MP0003315_abnormal_perineum_morphology | 1.40904592 |
73 | MP0005319_abnormal_enzyme/_coenzyme | 1.39243320 |
74 | MP0001293_anophthalmia | 1.37345111 |
75 | MP0003252_abnormal_bile_duct | 1.34866636 |
76 | MP0003186_abnormal_redox_activity | 1.32852781 |
77 | MP0006036_abnormal_mitochondrial_physio | 1.32235485 |
78 | MP0000467_abnormal_esophagus_morphology | 1.30596158 |
79 | MP0002452_abnormal_antigen_presenting | 1.29217694 |
80 | MP0002653_abnormal_ependyma_morphology | 1.25063427 |
81 | MP0003183_abnormal_peptide_metabolism | 1.24741957 |
82 | MP0005076_abnormal_cell_differentiation | 1.22575364 |
83 | MP0001853_heart_inflammation | 1.21681475 |
84 | MP0001819_abnormal_immune_cell | 1.19146094 |
85 | MP0006082_CNS_inflammation | 1.18529942 |
86 | MP0010329_abnormal_lipoprotein_level | 1.18132653 |
87 | MP0001879_abnormal_lymphatic_vessel | 1.15221430 |
88 | MP0000762_abnormal_tongue_morphology | 1.14270372 |
89 | MP0002420_abnormal_adaptive_immunity | 1.11507969 |
90 | MP0002722_abnormal_immune_system | 1.09820792 |
91 | MP0010155_abnormal_intestine_physiology | 1.08435512 |
92 | MP0001958_emphysema | 1.08087694 |
93 | MP0002092_abnormal_eye_morphology | 1.07558511 |
94 | MP0001849_ear_inflammation | 1.07462199 |
95 | MP0002088_abnormal_embryonic_growth/wei | 1.06253724 |
96 | MP0008877_abnormal_DNA_methylation | 1.06009259 |
97 | MP0005380_embryogenesis_phenotype | 1.05810881 |
98 | MP0001672_abnormal_embryogenesis/_devel | 1.05810881 |
99 | MP0003121_genomic_imprinting | 1.05007676 |
100 | MP0003984_embryonic_growth_retardation | 1.04668973 |
101 | MP0000703_abnormal_thymus_morphology | 1.04504207 |
102 | MP0002938_white_spotting | 1.04173158 |
103 | MP0000462_abnormal_digestive_system | 1.03843225 |
104 | MP0008057_abnormal_DNA_replication | 1.03229492 |
105 | MP0005085_abnormal_gallbladder_physiolo | 1.00660278 |
106 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.97068126 |
107 | MP0002932_abnormal_joint_morphology | 0.96958976 |
108 | MP0002876_abnormal_thyroid_physiology | 0.94898121 |
109 | MP0009278_abnormal_bone_marrow | 0.94804029 |
110 | MP0004885_abnormal_endolymph | 0.94302502 |
111 | MP0000858_altered_metastatic_potential | 0.93626736 |
112 | MP0001919_abnormal_reproductive_system | 0.93323396 |
113 | MP0003191_abnormal_cellular_cholesterol | 0.93010145 |
114 | MP0009840_abnormal_foam_cell | 0.90994687 |
115 | MP0008260_abnormal_autophagy | 0.89768290 |
116 | MP0005084_abnormal_gallbladder_morpholo | 0.89514512 |
117 | MP0010352_gastrointestinal_tract_polyps | 0.88728947 |
118 | MP0000689_abnormal_spleen_morphology | 0.88204210 |
119 | MP0010030_abnormal_orbit_morphology | 0.88073918 |
120 | MP0005266_abnormal_metabolism | 0.87786901 |
121 | MP0005390_skeleton_phenotype | 0.87529028 |
122 | MP0004484_altered_response_of | 0.87480409 |
123 | MP0000647_abnormal_sebaceous_gland | 0.86762067 |
124 | MP0001845_abnormal_inflammatory_respons | 0.84883577 |
125 | MP0001440_abnormal_grooming_behavior | 0.83624594 |
126 | MP0003806_abnormal_nucleotide_metabolis | 0.82628246 |
127 | MP0002277_abnormal_respiratory_mucosa | 0.82429716 |
128 | MP0005083_abnormal_biliary_tract | 0.82376940 |
129 | MP0002098_abnormal_vibrissa_morphology | 0.79991746 |
130 | MP0005397_hematopoietic_system_phenotyp | 0.79391522 |
131 | MP0001545_abnormal_hematopoietic_system | 0.79391522 |
132 | MP0002135_abnormal_kidney_morphology | 0.77748010 |
133 | MP0002398_abnormal_bone_marrow | 0.77462415 |
134 | MP0002405_respiratory_system_inflammati | 0.77095162 |
135 | MP0002127_abnormal_cardiovascular_syste | 0.76824549 |
136 | MP0002796_impaired_skin_barrier | 0.75951992 |
137 | MP0003879_abnormal_hair_cell | 0.75908502 |
138 | MP0001790_abnormal_immune_system | 0.74999840 |
139 | MP0005387_immune_system_phenotype | 0.74999840 |
140 | MP0000343_altered_response_to | 0.73369664 |
141 | MP0009931_abnormal_skin_appearance | 0.73058115 |
142 | MP0009763_increased_sensitivity_to | 0.72873218 |
143 | MP0004185_abnormal_adipocyte_glucose | 0.71845999 |
144 | MP0000716_abnormal_immune_system | 0.71470644 |
145 | MP0008469_abnormal_protein_level | 0.70489592 |
146 | MP0001216_abnormal_epidermal_layer | 0.70026497 |
147 | MP0002095_abnormal_skin_pigmentation | 0.69988232 |
148 | MP0003123_paternal_imprinting | 0.69918205 |
149 | MP0002114_abnormal_axial_skeleton | 0.68472032 |
150 | MP0005670_abnormal_white_adipose | 0.68466481 |
151 | MP0005253_abnormal_eye_physiology | 0.68315838 |
152 | MP0000432_abnormal_head_morphology | 0.67449648 |
153 | MP0002086_abnormal_extraembryonic_tissu | 0.67087855 |
154 | MP0002928_abnormal_bile_duct | 0.66314421 |
155 | MP0008569_lethality_at_weaning | 0.66055536 |
156 | MP0000750_abnormal_muscle_regeneration | 0.65594617 |
157 | MP0009764_decreased_sensitivity_to | 0.64523895 |
158 | MP0002429_abnormal_blood_cell | 0.64450495 |
159 | MP0002396_abnormal_hematopoietic_system | 0.63661750 |
160 | MP0002970_abnormal_white_adipose | 0.62309575 |
161 | MP0002085_abnormal_embryonic_tissue | 0.62084006 |
162 | MP0002233_abnormal_nose_morphology | 0.60347830 |
163 | MP0000609_abnormal_liver_physiology | 0.58911953 |
164 | MP0000538_abnormal_urinary_bladder | 0.57171020 |
165 | MP0002084_abnormal_developmental_patter | 0.56265284 |
166 | MP0001270_distended_abdomen | 0.55974954 |
167 | MP0002269_muscular_atrophy | 0.55443984 |
168 | MP0008789_abnormal_olfactory_epithelium | 0.55349861 |
169 | MP0004272_abnormal_basement_membrane | 0.54731700 |
170 | MP0005451_abnormal_body_composition | 0.53771188 |
171 | MP0000230_abnormal_systemic_arterial | 0.51867528 |
172 | MP0000049_abnormal_middle_ear | 0.51130750 |
173 | MP0002168_other_aberrant_phenotype | 0.50903242 |
174 | MP0000358_abnormal_cell_content/ | 0.49880199 |
175 | MP0000163_abnormal_cartilage_morphology | 0.49765193 |
176 | MP0000377_abnormal_hair_follicle | 0.49110739 |
177 | MP0001661_extended_life_span | 0.49039803 |
178 | MP0003137_abnormal_impulse_conducting | 0.48378254 |
179 | MP0000428_abnormal_craniofacial_morphol | 0.47976371 |
180 | MP0005376_homeostasis/metabolism_phenot | 0.47580937 |
181 | MP0009703_decreased_birth_body | 0.47406339 |
182 | MP0000534_abnormal_ureter_morphology | 0.46770889 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormal number of erythroid precursors (HP:0012131) | 8.15095423 |
2 | Stomach cancer (HP:0012126) | 7.68852859 |
3 | Abnormality of cells of the erythroid lineage (HP:0012130) | 6.92253605 |
4 | Gout (HP:0001997) | 6.70863095 |
5 | Prostate neoplasm (HP:0100787) | 6.45319768 |
6 | Hyperactive renin-angiotensin system (HP:0000841) | 6.22342682 |
7 | Increased circulating renin level (HP:0000848) | 6.07610027 |
8 | Hypomagnesemia (HP:0002917) | 6.04405614 |
9 | Metabolic alkalosis (HP:0200114) | 5.91360457 |
10 | Hypokalemic alkalosis (HP:0001949) | 5.66699844 |
11 | Prolonged neonatal jaundice (HP:0006579) | 5.65238886 |
12 | Abnormality of chloride homeostasis (HP:0011422) | 5.23950510 |
13 | Hyperglycinuria (HP:0003108) | 5.23532587 |
14 | Polyuria (HP:0000103) | 5.19762772 |
15 | Abnormality of magnesium homeostasis (HP:0004921) | 4.99582061 |
16 | Abnormal urine output (HP:0012590) | 4.95753223 |
17 | Hyperuricemia (HP:0002149) | 4.89214814 |
18 | Increased purine levels (HP:0004368) | 4.89214814 |
19 | Bilateral microphthalmos (HP:0007633) | 4.74172302 |
20 | Renal salt wasting (HP:0000127) | 4.68459242 |
21 | Hyperaldosteronism (HP:0000859) | 4.55050126 |
22 | Abnormality of chromosome segregation (HP:0002916) | 4.53815728 |
23 | Abnormality of renal excretion (HP:0011036) | 4.49107395 |
24 | Neoplasm of the peripheral nervous system (HP:0100007) | 4.36119540 |
25 | Hepatoblastoma (HP:0002884) | 4.35509500 |
26 | Proximal tubulopathy (HP:0000114) | 4.22624504 |
27 | Neuroendocrine neoplasm (HP:0100634) | 4.19482391 |
28 | Tetany (HP:0001281) | 4.17504763 |
29 | Polydipsia (HP:0001959) | 4.10609442 |
30 | Abnormal drinking behavior (HP:0030082) | 4.10609442 |
31 | Multiple enchondromatosis (HP:0005701) | 4.07204557 |
32 | Abnormality of glycine metabolism (HP:0010895) | 4.04629383 |
33 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.04629383 |
34 | Anhidrosis (HP:0000970) | 3.97823112 |
35 | Abnormality of renin-angiotensin system (HP:0000847) | 3.77981250 |
36 | Broad face (HP:0000283) | 3.72595643 |
37 | Spondylolisthesis (HP:0003302) | 3.68405093 |
38 | Growth hormone excess (HP:0000845) | 3.65434782 |
39 | Poikilocytosis (HP:0004447) | 3.60999905 |
40 | Abnormality of purine metabolism (HP:0004352) | 3.58398107 |
41 | Optic neuritis (HP:0100653) | 3.53253360 |
42 | Retrobulbar optic neuritis (HP:0100654) | 3.53253360 |
43 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.50100369 |
44 | Hypochromic microcytic anemia (HP:0004840) | 3.49374799 |
45 | Ketoacidosis (HP:0001993) | 3.48189933 |
46 | Conical tooth (HP:0000698) | 3.45048982 |
47 | Alkalosis (HP:0001948) | 3.40395559 |
48 | Hypercalciuria (HP:0002150) | 3.24865332 |
49 | Rimmed vacuoles (HP:0003805) | 3.20191380 |
50 | Reticulocytosis (HP:0001923) | 3.16040589 |
51 | Orchitis (HP:0100796) | 3.13363171 |
52 | Vacuolated lymphocytes (HP:0001922) | 3.07107854 |
53 | Type 2 muscle fiber atrophy (HP:0003554) | 3.05314983 |
54 | Malnutrition (HP:0004395) | 3.04504134 |
55 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.97961867 |
56 | Large hands (HP:0001176) | 2.97244061 |
57 | Renal tubular acidosis (HP:0001947) | 2.92690485 |
58 | Thyroid-stimulating hormone excess (HP:0002925) | 2.91766934 |
59 | Abnormality of the lower motor neuron (HP:0002366) | 2.88796652 |
60 | Hypokalemia (HP:0002900) | 2.83543439 |
61 | IgG deficiency (HP:0004315) | 2.82974114 |
62 | Hypoplasia of the uterus (HP:0000013) | 2.82894304 |
63 | Hypertensive crisis (HP:0100735) | 2.82012470 |
64 | Abnormality of the prostate (HP:0008775) | 2.81241777 |
65 | Rhabdomyosarcoma (HP:0002859) | 2.79548515 |
66 | Neoplasm of striated muscle (HP:0009728) | 2.76719440 |
67 | Abnormal cartilage morphology (HP:0002763) | 2.75382518 |
68 | Tinnitus (HP:0000360) | 2.74555955 |
69 | Fatigable weakness (HP:0003473) | 2.70396613 |
70 | Abnormality of the neuromuscular junction (HP:0003398) | 2.70396613 |
71 | Rib fusion (HP:0000902) | 2.68748278 |
72 | Agitation (HP:0000713) | 2.67872081 |
73 | Hyperventilation (HP:0002883) | 2.65454196 |
74 | Severe combined immunodeficiency (HP:0004430) | 2.62926701 |
75 | Ketosis (HP:0001946) | 2.60984191 |
76 | Hoarse voice (HP:0001609) | 2.56685789 |
77 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.56539751 |
78 | Stomatitis (HP:0010280) | 2.55290385 |
79 | Short tibia (HP:0005736) | 2.52125222 |
80 | Hyponatremia (HP:0002902) | 2.47959460 |
81 | Abnormality of sodium homeostasis (HP:0010931) | 2.47089174 |
82 | Muscle fiber atrophy (HP:0100295) | 2.46945491 |
83 | Hyperglycinemia (HP:0002154) | 2.46290000 |
84 | Duplicated collecting system (HP:0000081) | 2.46186379 |
85 | Abnormality of nucleobase metabolism (HP:0010932) | 2.45015084 |
86 | Keratoconjunctivitis sicca (HP:0001097) | 2.44224695 |
87 | Abnormality of eosinophils (HP:0001879) | 2.43424547 |
88 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.42967740 |
89 | Delayed CNS myelination (HP:0002188) | 2.42872739 |
90 | Osteolytic defects of the hand bones (HP:0009699) | 2.40604871 |
91 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.40604871 |
92 | Ragged-red muscle fibers (HP:0003200) | 2.40411889 |
93 | Myositis (HP:0100614) | 2.40005172 |
94 | Renal cortical cysts (HP:0000803) | 2.39298450 |
95 | Abnormality of the frontal sinuses (HP:0002687) | 2.38842809 |
96 | Abnormality of male internal genitalia (HP:0000022) | 2.38698359 |
97 | Abnormality of potassium homeostasis (HP:0011042) | 2.33830240 |
98 | Ependymoma (HP:0002888) | 2.33414639 |
99 | Nephrocalcinosis (HP:0000121) | 2.31691396 |
100 | Increased connective tissue (HP:0009025) | 2.29376922 |
101 | Delayed epiphyseal ossification (HP:0002663) | 2.26280071 |
102 | Abnormality of reticulocytes (HP:0004312) | 2.25000200 |
103 | Testicular atrophy (HP:0000029) | 2.23994607 |
104 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.19582456 |
105 | Tubular atrophy (HP:0000092) | 2.19434368 |
106 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.17818264 |
107 | Dehydration (HP:0001944) | 2.17687439 |
108 | White forelock (HP:0002211) | 2.17287855 |
109 | Abnormality of the renal cortex (HP:0011035) | 2.16307468 |
110 | Pelvic girdle muscle weakness (HP:0003749) | 2.15805990 |
111 | Hand muscle atrophy (HP:0009130) | 2.14336088 |
112 | Keratoconjunctivitis (HP:0001096) | 2.13254177 |
113 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.12974560 |
114 | Metabolic acidosis (HP:0001942) | 2.11993827 |
115 | Combined immunodeficiency (HP:0005387) | 2.10920971 |
116 | Vomiting (HP:0002013) | 2.07066670 |
117 | Abnormality of the renal collecting system (HP:0004742) | 2.05276230 |
118 | Nephrolithiasis (HP:0000787) | 2.03534793 |
119 | Shawl scrotum (HP:0000049) | 2.03283740 |
120 | Partial duplication of thumb phalanx (HP:0009944) | 2.02237491 |
121 | Generalized aminoaciduria (HP:0002909) | 2.02223798 |
122 | Metaphyseal cupping (HP:0003021) | 2.01517648 |
123 | Hyperphosphaturia (HP:0003109) | 2.00603237 |
124 | Widely patent fontanelles and sutures (HP:0004492) | 2.00565298 |
125 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.99701008 |
126 | Vaginal fistula (HP:0004320) | 1.99549988 |
127 | Dicarboxylic aciduria (HP:0003215) | 1.99405737 |
128 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.99405737 |
129 | Rectal fistula (HP:0100590) | 1.99272181 |
130 | Rectovaginal fistula (HP:0000143) | 1.99272181 |
131 | Abnormality of the endocardium (HP:0004306) | 1.98837271 |
132 | Xerostomia (HP:0000217) | 1.98559569 |
133 | Short humerus (HP:0005792) | 1.98152595 |
134 | Chondrocalcinosis (HP:0000934) | 1.97998988 |
135 | Pulmonary infiltrates (HP:0002113) | 1.97487503 |
136 | Hyperpituitarism (HP:0010514) | 1.96918760 |
137 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.96448595 |
138 | Rickets (HP:0002748) | 1.96394235 |
139 | Abnormality of dental color (HP:0011073) | 1.94785081 |
140 | Abnormality of the vocal cords (HP:0008777) | 1.94281420 |
141 | Lymphangioma (HP:0100764) | 1.94135592 |
142 | Hyperammonemia (HP:0001987) | 1.92794158 |
143 | Onycholysis (HP:0001806) | 1.92083311 |
144 | Pili torti (HP:0003777) | 1.91993235 |
145 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.90494728 |
146 | Decreased central vision (HP:0007663) | 1.90287092 |
147 | Increased serum pyruvate (HP:0003542) | 1.88622303 |
148 | Abnormality of glycolysis (HP:0004366) | 1.88622303 |
149 | Hypophosphatemia (HP:0002148) | 1.87857052 |
150 | Adrenal overactivity (HP:0002717) | 1.87599776 |
151 | Enlarged kidneys (HP:0000105) | 1.87303301 |
152 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.87224212 |
153 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.87061766 |
154 | Glycosuria (HP:0003076) | 1.86541513 |
155 | Abnormality of urine glucose concentration (HP:0011016) | 1.86541513 |
156 | Abnormality of Sharpey fibers (HP:0100685) | 1.86344064 |
157 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.85775791 |
158 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.85775791 |
159 | Neoplasm of the heart (HP:0100544) | 1.85628993 |
160 | Wide cranial sutures (HP:0010537) | 1.85266324 |
161 | Shoulder girdle muscle weakness (HP:0003547) | 1.83590087 |
162 | Bifid tongue (HP:0010297) | 1.83546591 |
163 | Abnormal urine phosphate concentration (HP:0012599) | 1.83091649 |
164 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.82003474 |
165 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.80632780 |
166 | Flat capital femoral epiphysis (HP:0003370) | 1.80252623 |
167 | Spastic tetraparesis (HP:0001285) | 1.77530082 |
168 | Irritability (HP:0000737) | 1.75854105 |
169 | T lymphocytopenia (HP:0005403) | 1.75486290 |
170 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.75159347 |
171 | Type II lissencephaly (HP:0007260) | 1.74916427 |
172 | Mitral stenosis (HP:0001718) | 1.74107321 |
173 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.73524729 |
174 | Abnormality of the salivary glands (HP:0010286) | 1.73290949 |
175 | Thyroiditis (HP:0100646) | 1.72551220 |
176 | Hypoplasia of the fovea (HP:0007750) | 1.71678602 |
177 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.71678602 |
178 | Camptodactyly of toe (HP:0001836) | 1.71152123 |
179 | Hypotension (HP:0002615) | 1.70899565 |
180 | Prominent nose (HP:0000448) | 1.70875059 |
181 | Resting tremor (HP:0002322) | 1.70423155 |
182 | Partial duplication of the phalanx of hand (HP:0009999) | 1.70344162 |
183 | Neoplasm of head and neck (HP:0012288) | 1.70040516 |
184 | Esophageal neoplasm (HP:0100751) | 1.70040516 |
185 | Anomalous pulmonary venous return (HP:0010772) | 1.69028480 |
186 | Congenital sensorineural hearing impairment (HP:0008527) | 1.68805723 |
187 | Easy fatigability (HP:0003388) | 1.67989786 |
Rank | Gene Set | Z-score |
---|---|---|
1 | WNK3 | 6.60566131 |
2 | CDK12 | 6.28340012 |
3 | OXSR1 | 4.52631192 |
4 | GRK5 | 4.49092611 |
5 | GRK6 | 4.15159082 |
6 | WNK4 | 4.04762911 |
7 | MAP2K2 | 3.87492183 |
8 | ERN1 | 3.79217006 |
9 | MAPKAPK3 | 3.38639532 |
10 | MAP3K14 | 3.04598785 |
11 | GRK1 | 2.79539387 |
12 | ADRBK2 | 2.64833156 |
13 | VRK2 | 2.62910848 |
14 | WNK1 | 2.62842075 |
15 | BRD4 | 2.40282212 |
16 | BUB1 | 2.38493736 |
17 | TGFBR2 | 2.33739526 |
18 | CSF1R | 2.14756014 |
19 | KSR2 | 2.10678918 |
20 | TESK2 | 10.9341421 |
21 | TTK | 1.97413736 |
22 | CCNB1 | 1.93983603 |
23 | IKBKE | 1.91932885 |
24 | IKBKB | 1.88380718 |
25 | TYRO3 | 1.84803883 |
26 | STK10 | 1.80749934 |
27 | GRK7 | 1.75789035 |
28 | MATK | 1.73969720 |
29 | RAF1 | 1.73735552 |
30 | MAPK7 | 1.69316579 |
31 | MARK3 | 1.62178451 |
32 | TBK1 | 1.59197776 |
33 | KSR1 | 1.56984658 |
34 | BMPR2 | 1.50629727 |
35 | STK39 | 1.50294287 |
36 | CAMKK2 | 1.46489616 |
37 | KIT | 1.44312550 |
38 | STK38L | 1.43225966 |
39 | MOS | 1.42036896 |
40 | NTRK1 | 1.40697328 |
41 | MAP2K1 | 1.39061796 |
42 | BCKDK | 1.38391011 |
43 | RPS6KA2 | 1.36227634 |
44 | PAK6 | 1.30002197 |
45 | TAOK3 | 1.27598099 |
46 | PDK3 | 1.27166450 |
47 | PDK4 | 1.27166450 |
48 | NEK1 | 1.26072650 |
49 | JAK1 | 1.21463309 |
50 | ARAF | 1.17920812 |
51 | CAMK4 | 1.17599348 |
52 | ZAK | 1.12387186 |
53 | MAP3K13 | 1.11992165 |
54 | PAK4 | 1.11947399 |
55 | MAP4K1 | 1.10646112 |
56 | PRKG2 | 1.09493682 |
57 | DAPK1 | 1.03540742 |
58 | PDK2 | 1.03501153 |
59 | PRKCH | 1.02752832 |
60 | STK38 | 0.98070756 |
61 | MAP2K4 | 0.96109633 |
62 | MAP3K12 | 0.95554340 |
63 | FRK | 0.90139535 |
64 | CHUK | 0.88866313 |
65 | EPHA2 | 0.87963343 |
66 | ADRBK1 | 0.87088854 |
67 | MARK2 | 0.86514977 |
68 | MAP3K7 | 0.85684135 |
69 | TLK1 | 0.85125438 |
70 | CDK7 | 0.84472901 |
71 | IRAK3 | 0.78324413 |
72 | RPS6KC1 | 0.76344594 |
73 | RPS6KL1 | 0.76344594 |
74 | TRPM7 | 0.75362036 |
75 | AKT3 | 0.72664373 |
76 | AKT2 | 0.69911736 |
77 | RPS6KA6 | 0.69695929 |
78 | CDK3 | 0.68531418 |
79 | CHEK2 | 0.66769037 |
80 | MAP2K7 | 0.66302024 |
81 | MAP2K6 | 0.65576408 |
82 | MST4 | 0.64713954 |
83 | SGK223 | 0.63649950 |
84 | SGK494 | 0.63649950 |
85 | FGFR3 | 0.62710187 |
86 | EEF2K | 0.62193581 |
87 | PRKCI | 0.60678560 |
88 | MYLK | 0.60486243 |
89 | MAPK12 | 0.57869414 |
90 | MAP3K10 | 0.55343530 |
91 | PTK2 | 0.54031936 |
92 | PIM1 | 0.53983141 |
93 | HIPK2 | 0.53950193 |
94 | PLK1 | 0.53884848 |
95 | PRKAA1 | 0.52132356 |
96 | CSK | 0.52048734 |
97 | KDR | 0.51130205 |
98 | GSK3A | 0.51021401 |
99 | PKN2 | 0.50162418 |
100 | SIK1 | 0.46212955 |
101 | SIK3 | 0.45017908 |
102 | LATS2 | 0.44464011 |
103 | PRKCD | 0.39028943 |
104 | MTOR | 0.38621387 |
105 | FLT3 | 0.37410110 |
106 | JAK3 | 0.37242979 |
107 | ALK | 0.36183395 |
108 | RPS6KA1 | 0.35685446 |
109 | IGF1R | 0.35400515 |
110 | SIK2 | 0.35110542 |
111 | VRK1 | 0.35024052 |
112 | PINK1 | 0.33178158 |
113 | PRKD2 | 0.31325815 |
114 | RIPK1 | 0.30579820 |
115 | DYRK1B | 0.28433525 |
116 | CHEK1 | 0.27485442 |
117 | PRKACG | 0.27291500 |
118 | PAK3 | 0.26984546 |
119 | IRAK1 | 0.26645260 |
120 | TXK | 0.26209016 |
121 | SGK3 | 0.25812721 |
122 | ITK | 0.25429668 |
123 | MAPK13 | 0.25062272 |
124 | LIMK1 | 0.24786007 |
125 | AURKA | 0.24489064 |
126 | CAMKK1 | 0.22517877 |
127 | LCK | 0.22435060 |
128 | LRRK2 | 0.22248568 |
129 | ERBB2 | 0.22068921 |
130 | MAPKAPK2 | 0.21074351 |
131 | EIF2AK2 | 0.20226944 |
132 | MST1R | 0.19996378 |
133 | CSNK1E | 0.19901579 |
134 | SGK2 | 0.19451050 |
135 | MAP3K1 | 0.18369757 |
136 | PDGFRA | 0.17829077 |
137 | CDK6 | 0.17222879 |
138 | IRAK4 | 0.16393586 |
139 | PDK1 | 0.15899371 |
140 | STK11 | 0.15621784 |
141 | BMX | 0.15430949 |
142 | MAPK1 | 0.15373021 |
143 | PRKCG | 0.15351865 |
144 | INSR | 0.15300344 |
145 | PRKACA | 0.14884076 |
146 | NEK2 | 0.14858788 |
147 | PDPK1 | 0.14179629 |
148 | EPHA4 | 0.13171647 |
149 | NEK6 | 0.13135771 |
150 | PRKAA2 | 0.12153295 |
151 | CDK2 | 0.11877095 |
152 | JAK2 | 0.11619204 |
153 | MAPK3 | 0.11617807 |
154 | ABL2 | 0.11269046 |
155 | MAP3K3 | 0.10804285 |
156 | NEK9 | 0.10676747 |
157 | PRKACB | 0.10537747 |
158 | FGFR4 | 0.09813015 |
159 | MAPK4 | 0.09724412 |
160 | PAK1 | 0.09236888 |
161 | STK16 | 0.09178315 |
162 | MAPK10 | 0.09014029 |
163 | CDK4 | 0.05728749 |
164 | LATS1 | 0.05710945 |
165 | RPS6KA3 | 0.05417711 |
166 | MAP3K9 | 0.05320571 |
167 | AURKB | 0.04997024 |
168 | TAOK1 | 0.04722551 |
169 | SGK1 | 0.04720295 |
170 | MAPK11 | 0.04522134 |
171 | DYRK1A | 0.03412134 |
Rank | Gene Set | Z-score |
---|---|---|
1 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.79244015 |
2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.75543062 |
3 | Circadian rhythm_Homo sapiens_hsa04710 | 3.60004663 |
4 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.42671021 |
5 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.31969547 |
6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.27992893 |
7 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.06747139 |
8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.06112619 |
9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.93957164 |
10 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.90926128 |
11 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.87644515 |
12 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.66716523 |
13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.52991631 |
14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.46774940 |
15 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.29463196 |
16 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.14775489 |
17 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.14343073 |
18 | Peroxisome_Homo sapiens_hsa04146 | 2.02335669 |
19 | Malaria_Homo sapiens_hsa05144 | 2.00131695 |
20 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.97268259 |
21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.93496986 |
22 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.90989704 |
23 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.89752631 |
24 | Leishmaniasis_Homo sapiens_hsa05140 | 1.88586121 |
25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.86923505 |
26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.86095996 |
27 | Carbon metabolism_Homo sapiens_hsa01200 | 1.77627973 |
28 | Bile secretion_Homo sapiens_hsa04976 | 1.72342991 |
29 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.67597048 |
30 | ABC transporters_Homo sapiens_hsa02010 | 1.66355467 |
31 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.65937726 |
32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.65461390 |
33 | Legionellosis_Homo sapiens_hsa05134 | 1.61491949 |
34 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.60745825 |
35 | Measles_Homo sapiens_hsa05162 | 1.59757657 |
36 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.57345483 |
37 | Other glycan degradation_Homo sapiens_hsa00511 | 1.53923064 |
38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.53730165 |
39 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.52841906 |
40 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.52204949 |
41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.52123267 |
42 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.49905111 |
43 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.47877572 |
44 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.45509046 |
45 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.44737147 |
46 | Pertussis_Homo sapiens_hsa05133 | 1.40956227 |
47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.40134567 |
48 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.37030233 |
49 | Galactose metabolism_Homo sapiens_hsa00052 | 1.35302857 |
50 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.33889156 |
51 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.33805453 |
52 | Hepatitis C_Homo sapiens_hsa05160 | 1.33125800 |
53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.32998089 |
54 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.30685788 |
55 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.30200843 |
56 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.28555062 |
57 | Lysine degradation_Homo sapiens_hsa00310 | 1.25536674 |
58 | Influenza A_Homo sapiens_hsa05164 | 1.23923543 |
59 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.20803142 |
60 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.19301351 |
61 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.19014682 |
62 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.16010094 |
63 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.14397094 |
64 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.13602767 |
65 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.12296493 |
66 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.12293686 |
67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.10383806 |
68 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.10044261 |
69 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.09990911 |
70 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.08700364 |
71 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.06793559 |
72 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.03125372 |
73 | Apoptosis_Homo sapiens_hsa04210 | 1.01036402 |
74 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.00683349 |
75 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.96276547 |
76 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.95074575 |
77 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.94711974 |
78 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.93312383 |
79 | Phototransduction_Homo sapiens_hsa04744 | 0.92071759 |
80 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.91707282 |
81 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.91117484 |
82 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.90936295 |
83 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.87867384 |
84 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.86683873 |
85 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.85857210 |
86 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.84116973 |
87 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.83668784 |
88 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.83396993 |
89 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.81913704 |
90 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.80398603 |
91 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.79755525 |
92 | Mineral absorption_Homo sapiens_hsa04978 | 0.79484144 |
93 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.78787829 |
94 | Basal transcription factors_Homo sapiens_hsa03022 | 0.78165763 |
95 | Hepatitis B_Homo sapiens_hsa05161 | 0.78055948 |
96 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.77724284 |
97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.77577568 |
98 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.75093773 |
99 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.73458864 |
100 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.72852639 |
101 | Sulfur relay system_Homo sapiens_hsa04122 | 0.72585401 |
102 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.72290439 |
103 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.71128837 |
104 | Colorectal cancer_Homo sapiens_hsa05210 | 0.70804829 |
105 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.70449278 |
106 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68330085 |
107 | Long-term potentiation_Homo sapiens_hsa04720 | 0.64392580 |
108 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.63227021 |
109 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62906855 |
110 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.62656207 |
111 | Metabolic pathways_Homo sapiens_hsa01100 | 0.61656971 |
112 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.60014966 |
113 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.54949436 |
114 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53048733 |
115 | Insulin resistance_Homo sapiens_hsa04931 | 0.52990318 |
116 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52654822 |
117 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.52573087 |
118 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.52157116 |
119 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.51807226 |
120 | Endocytosis_Homo sapiens_hsa04144 | 0.51552457 |
121 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51345305 |
122 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.50491365 |
123 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.50472400 |
124 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.48542501 |
125 | HTLV-I infection_Homo sapiens_hsa05166 | 0.47701320 |
126 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.46934249 |
127 | Lysosome_Homo sapiens_hsa04142 | 0.44078347 |
128 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.43389590 |
129 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.43389328 |
130 | Retinol metabolism_Homo sapiens_hsa00830 | 0.42444950 |
131 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.42368906 |
132 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41613319 |
133 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.37748816 |
134 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.37047649 |
135 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.36542953 |
136 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.35273476 |
137 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35211663 |
138 | Salivary secretion_Homo sapiens_hsa04970 | 0.35003751 |
139 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.34796101 |
140 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.34544521 |
141 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.32706597 |
142 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.32640630 |
143 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.32540536 |
144 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.30368905 |
145 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.30366290 |
146 | Histidine metabolism_Homo sapiens_hsa00340 | 0.30193709 |
147 | Prostate cancer_Homo sapiens_hsa05215 | 0.29902255 |
148 | Prion diseases_Homo sapiens_hsa05020 | 0.26531699 |
149 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.25387149 |
150 | Thyroid cancer_Homo sapiens_hsa05216 | 0.24940353 |
151 | Shigellosis_Homo sapiens_hsa05131 | 0.24764052 |
152 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.24612579 |
153 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.24296497 |
154 | Amoebiasis_Homo sapiens_hsa05146 | 0.24079293 |
155 | Melanogenesis_Homo sapiens_hsa04916 | 0.23205153 |
156 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.23162278 |
157 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.23081998 |
158 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.22989436 |
159 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.21496464 |
160 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.19179835 |
161 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.18548451 |
162 | Bladder cancer_Homo sapiens_hsa05219 | 0.17017677 |
163 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.16653578 |
164 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.13300149 |
165 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.11727328 |
166 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.11213905 |
167 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.10731892 |
168 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.10248452 |
169 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.08698176 |
170 | Tight junction_Homo sapiens_hsa04530 | 0.07095246 |
171 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.06624996 |
172 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.05984390 |
173 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.05568050 |
174 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.05380910 |
175 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.05217981 |
176 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.05206008 |
177 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.04845079 |
178 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.03041134 |